Coherus Oncology (CHRS) Return on Capital Employed [ROCE] (2014 - 2026)
Coherus Oncology (CHRS) posted Return on Capital Employed [ROCE] of -103.66% for Q2 2026, up 25.66 percentage points from -129.32% a year earlier and up 28.68 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Coherus Oncology's Return on Capital Employed [ROCE] came in at -85.02%, down 7.06 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -117.61 percentage points (FY2020 to FY2025).
- In prior years, Coherus Oncology's Return on Capital Employed [ROCE] was -77.96% in FY2024 (+12.97 pp), -90.94% in FY2023 (-32.74 pp), -58.20% in FY2022 (-13.86 pp) and -44.33% in FY2021 (-76.92 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -170.91% in Q3 2025 to a high of -36.76% in Q1 2022 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -16.48 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 29.71 percentage points; the weakest was Q3 2025, with a drop of 95.09 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -132.34% (Q1 2026), -73.32% (Q4 2025) and -170.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 43.74% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.33% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 11.32% |
| 10 | Coherus Oncology | 119.30 Mn | -516.84 Mn | 10.07 Mn | -103.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -103.66% |
| Mar 31, 2026 | -132.34% |
| Dec 31, 2025 | -73.32% |
| Sep 30, 2025 | -170.91% |
| Jun 30, 2025 | -129.32% |
| Mar 31, 2025 | -114.57% |
| Dec 31, 2024 | -103.03% |
| Sep 30, 2024 | -75.82% |
| Jun 30, 2024 | -81.31% |
| Mar 31, 2024 | -128.41% |
| Dec 31, 2023 | -73.91% |
| Sep 30, 2023 | -64.73% |
| Jun 30, 2023 | -87.87% |
| Mar 31, 2023 | -76.58% |
| Dec 31, 2022 | -68.10% |
| Sep 30, 2022 | -64.95% |
| Jun 30, 2022 | -45.99% |
| Mar 31, 2022 | -36.76% |
| Dec 31, 2021 | -48.40% |
| Sep 30, 2021 | -49.46% |
API Access
Coherus Oncology Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();